A detailed history of Grandview Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Grandview Asset Management LLC holds 18,047 shares of ABBV stock, worth $3.23 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
18,047
Previous 18,215 0.92%
Holding current value
$3.23 Million
Previous $3.12 Million 14.08%
% of portfolio
2.04%
Previous 1.83%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $27,525 - $33,487
-168 Reduced 0.92%
18,047 $3.56 Million
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $51,854 - $60,554
-335 Reduced 1.81%
18,215 $3.12 Million
Q1 2024

Apr 10, 2024

SELL
$159.82 - $182.1 $47,946 - $54,630
-300 Reduced 1.59%
18,550 $3.38 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $105,814 - $119,171
-769 Reduced 3.92%
18,850 $2.92 Million
Q3 2023

Oct 27, 2023

SELL
$133.59 - $154.65 $198,915 - $230,273
-1,489 Reduced 7.05%
19,619 $2.92 Million
Q2 2023

Jul 07, 2023

SELL
$132.51 - $164.9 $246,998 - $307,373
-1,864 Reduced 8.11%
21,108 $2.84 Million
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $333,181 - $383,708
-2,304 Reduced 9.12%
22,972 $3.66 Million
Q4 2022

Jan 09, 2023

SELL
$138.31 - $165.87 $162,237 - $194,565
-1,173 Reduced 4.43%
25,276 $4.09 Million
Q3 2022

Oct 11, 2022

SELL
$134.21 - $153.93 $158,502 - $181,791
-1,181 Reduced 4.27%
26,449 $3.55 Million
Q2 2022

Jul 11, 2022

SELL
$137.62 - $174.96 $118,766 - $150,990
-863 Reduced 3.03%
27,630 $4.23 Million
Q1 2022

Apr 26, 2022

SELL
$131.98 - $163.75 $71,401 - $88,588
-541 Reduced 1.86%
28,493 $4.62 Million
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $57,582 - $72,858
536 Added 1.88%
29,034 $3.93 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $20,428 - $23,189
-192 Reduced 0.67%
28,498 $3.07 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $284,382 - $316,818
2,703 Added 10.4%
28,690 $3.23 Million
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $2.64 Million - $2.9 Million
25,787 Added 12893.5%
25,987 $2.81 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $2.66 Million - $2.93 Million
-25,993 Reduced 99.24%
200 $42,000
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $31,793 - $42,924
395 Added 1.53%
26,193 $2.81 Million
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $111,339 - $130,675
-1,296 Reduced 4.78%
25,798 $2.26 Million
Q2 2020

Jul 23, 2020

BUY
$73.37 - $98.18 $1.99 Million - $2.66 Million
27,094 New
27,094 $2.66 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Grandview Asset Management LLC Portfolio

Follow Grandview Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandview Asset Management LLC with notifications on news.